Stress-induced immunosuppression affecting immune response to Newcastle disease virus vaccine through "miR-155-CTLA-4" pathway in chickens

PeerJ. 2023 Feb 27:11:e14529. doi: 10.7717/peerj.14529. eCollection 2023.

Abstract

MiR-155 and CTLA-4 are important factors involved in the regulation of immune function. However, there is no report about their involvement in function regulation of stress-induced immunosuppression affecting immune response. In this study, the chicken model of stress-induced immunosuppression affecting immune response (simulation with dexamethasone and immunization with Newcastle disease virus (NDV) attenuated vaccine) was established, then the expression characteristics of miR-155 and CTLA-4 gene were analyzed at several key time points during the processes of stress-induced immunosuppression affecting NDV vaccine immune response at serum and tissue levels. The results showed that miR-155 and CTLA-4 were the key factors involved in stress-induced immunosuppression and NDV immune response, whose functions involved in the regulation of immune function were different in different tissues and time points, and 2 day post immunization (dpi), 5dpi and 21dpi were the possible key regulatory time points. CTLA-4, the target gene of miR-155, had significant game regulation relationships between them in various tissues, such as bursa of Fabricius, thymus and liver, indicating that miR-155-CTLA-4 pathway was one of the main mechanisms of their involvement in the regulations of stress-induced immunosuppression affecting NDV immune response. This study can lay the foundation for in-depth exploration of miR-155-CTLA-4 pathway involved in the regulation of immune function.

Keywords: CTLA-4 gene; Chicken; MiR-155; Newcastle disease virus; Stress-induced immunosuppression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CTLA-4 Antigen
  • Chickens*
  • Immunity
  • Immunosuppression Therapy
  • MicroRNAs*
  • Newcastle disease virus
  • Vaccines, Attenuated

Substances

  • CTLA-4 Antigen
  • Vaccines, Attenuated
  • MicroRNAs

Grants and funding

This work was supported by the Science Foundation of Heilongjiang Province (grant number LH2019C073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.